GLUCOTROL XL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Glucotrol Xl, and what generic alternatives are available?
Glucotrol Xl is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in GLUCOTROL XL is glipizide. There are eighteen drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the glipizide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Glucotrol Xl
A generic version of GLUCOTROL XL was approved as glipizide by AUROBINDO PHARMA USA on May 10th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLUCOTROL XL?
- What are the global sales for GLUCOTROL XL?
- What is Average Wholesale Price for GLUCOTROL XL?
Summary for GLUCOTROL XL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Clinical Trials: | 15 |
| Patent Applications: | 4,311 |
| Drug Prices: | Drug price information for GLUCOTROL XL |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GLUCOTROL XL |
| What excipients (inactive ingredients) are in GLUCOTROL XL? | GLUCOTROL XL excipients list |
| DailyMed Link: | GLUCOTROL XL at DailyMed |
See drug prices for GLUCOTROL XL
Recent Clinical Trials for GLUCOTROL XL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Memorial Sloan Kettering Cancer Center | Phase 2 |
| Baylor College of Medicine | Phase 4 |
| Novartis | Phase 2 |
Pharmacology for GLUCOTROL XL
| Drug Class | Sulfonylurea |
US Patents and Regulatory Information for GLUCOTROL XL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-003 | Aug 10, 1999 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-001 | Apr 26, 1994 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GLUCOTROL XL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-001 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-001 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-003 | Aug 10, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-002 | Apr 26, 1994 | ⤷ Sign Up | ⤷ Sign Up |
| Pfizer | GLUCOTROL XL | glipizide | TABLET, EXTENDED RELEASE;ORAL | 020329-003 | Aug 10, 1999 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GLUCOTROL XL
See the table below for patents covering GLUCOTROL XL around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 394944 | ⤷ Sign Up | |
| Norway | 920740 | ⤷ Sign Up | |
| Netherlands | 192250 | ⤷ Sign Up | |
| Mexico | 9203733 | DISPOSITIVO OSMOTICO PARA ADMINISTRAR CIERTAS DROGAS. | ⤷ Sign Up |
| Austria | 94393 | ⤷ Sign Up | |
| Mexico | 9203553 | DISPOSITIVO OSMOTICO CON UN MIEMBRO IMPULSOR DE HIDROGEL. | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
